Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report

BACKGORUND: Mixed hyperlipidemia is common in patients with diabetes. Statins, the choice drugs, are effective at reducing lipoproteins that contain apolipoprotein B100, but they fail to exert good control over intestinal lipoproteins, which have an atherogenic potential. We describe the effect of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdivielso, Pedro, Rioja, José, García-Arias, Carlota, Sánchez-Chaparro, Miguel Angel, González-Santos, Pedro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631503/
https://www.ncbi.nlm.nih.gov/pubmed/19133114
http://dx.doi.org/10.1186/1475-2840-8-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631503/
https://www.ncbi.nlm.nih.gov/pubmed/19133114
http://dx.doi.org/10.1186/1475-2840-8-1

Ejemplares similares